Antonis  Koromilas



Lady Davis Institute
Jewish General Hospital
3755 Côte Ste. Catherine Road
Montreal, QC H3T 1E2

Telephone: 514-340-8260 X 23697

Education: Ph.D., B.Sc., Aristotelian University of Thessaloniki, Greece

Research Focus: Signal Transduction; Virus Infection; Virus-Mediated Oncogenesis; Protein Phosphorylation; mRNA Translation, Cell Cycle Control; Cell Proliferation; Apoptosis; Interferon; Endoplasmic-Reticulum Stress; Tumour Suppressor p53.

Recent Presentations:

Tenkerian C, Krishnamoorthy JL, Wang S, Kazimierczak U, Rajesh K, Koromilas AE (2014) “Disruption of mTORC2‐Akt axis determines cell adaptation and response to stress through the induction of eIF2α serine 51 phosphorylation pathway.” Cold Spring Harbor Meeting on Translational Control, Cold Spring Harbor Laboratory, New York, USA (September 2‐6, 2014).

Koromilas AE, Tenkerian C, Krishnamoorthy JL, Rajesh K, Kazimierczak U, Wang S. (2014) “eIF2α serine 51 phosphorylation determines the adaptation of TSC mutant cells to stress in response to anti‐tumor therapies.” 26th EORTCNCI‐ AACR Symposium on Molecular Targets and Cancer Therapeutics, Barcelona, Spain (November 18‐21, 2014).

Koromilas AE 4th World Congress on Cancer Science & Therapy, Chicago, USA (October 20‐22, 2014). Title: “Cell fate decisions and anti‐tumor effects of the mRNA translation initiation factor eIF2.” Organized by OMICS Group Conferences.

Koromilas AE PCS Global Cancer Conference, Athens, Greece (October 31‐November 3, 2014). Title: “Cell fate decisions and antitumor effects of the mRNA translation initiation factor eIF2.” Organized by Pioneer Century Science (PCS) Limited.

Recent Publications:

Please click here for Dr. Antonis Koromilas’ complete publication list.